The national abortion landscape was shaken again this week as Florida’s six-week abortion ban took effect.
POINT’s prostate cancer trial meets primary endpoint as Lilly’s offer looms – Pharmaceutical Technology
Share this article Credit: Michael Vi / Shutterstock.com US-based Lantheus and POINT Biopharma have announced positive topline data from the Phase III trial investigating prostate